Elevate Capital Advisors, LLC Roivant Sciences Ltd. Transaction History
Elevate Capital Advisors, LLC
- $125 Billion
- Q2 2025
A detailed history of Elevate Capital Advisors, LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Elevate Capital Advisors, LLC holds 116,026 shares of ROIV stock, worth $1.34 Million. This represents 1.04% of its overall portfolio holdings.
Number of Shares
116,026
Previous 177,394
34.59%
Holding current value
$1.34 Million
Previous $1.79 Billion
26.95%
% of portfolio
1.04%
Previous 1.66%
Shares
3 transactions
Others Institutions Holding ROIV
# of Institutions
362Shares Held
456MCall Options Held
8.36MPut Options Held
760K-
Sb Investment Advisers (Uk) LTD London, X060MShares$694 Million5.36% of portfolio
-
Morgan Stanley New York, NY44.7MShares$517 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.3MShares$455 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$409 Million0.01% of portfolio
-
Viking Global Investors LP34.2MShares$396 Million1.22% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.15B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...